[{"Assets_0_Q2_USD":65151000.0,"CommonStockSharesOutstanding_0_Q2_shares":1870286.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-21971000.0,"NetIncomeLoss_1_Q2_USD":-13169000.0,"NetIncomeLoss_2_Q2_USD":-50012000.0,"StockholdersEquity_0_Q2_USD":-111681000.0,"Ticker":"FULC","CIK":"1680581","name":"FULCRUM THERAPEUTICS, INC.","OfficialName":"Fulcrum Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"518124504.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190826"}]